Page last updated: 2024-08-24

tenofovir and Chronic Kidney Diseases

tenofovir has been researched along with Chronic Kidney Diseases in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	32 (72.73)	24.3611
2020's	12 (27.27)	2.80

Authors

Authors	Studies
Amagase, H; Azuma, K; Dohmen, K; Furusyo, N; Hayashi, J; Ichiki, Y; Kajiwara, E; Kato, M; Kawano, A; Koyanagi, T; Kuniyoshi, M; Morita, C; Nakamuta, M; Nomura, H; Ogawa, E; Ooho, A; Satoh, T; Shimoda, S; Sugimoto, R; Takahashi, K; Yamashita, N	2
Ahn, SH; Jung, CY; Kim, BS; Kim, HW; Kim, SU; Lee, HW; Lee, JI	1
Cai, L; Guo, Z; He, S; Wang, Y; Wang, Z; Yan, D; Yang, X; Zheng, Y	1
Alves Saldanha, S; Andre, P; Buclin, T; Cavassini, M; Courlet, P; Decosterd, LA; Desfontaine, V; Guidi, M; Kusejko, K; Thoueille, P	1
Singh, S	1
Adoua Doukaga, T; Axel Aloumba, G; Bienvenue Ossibi Ibara, R; Boumandoki, P; Diafouka, M; Herbas Ekat, M; Mahambou-Nsonde, D; Obengui, P; Roger Nzounza, P; Seydi, M; Tidiane Ndour, C	1
Bogner, JR; Hilge, R; Schrader, SY; Seybold, U; Zeder, AJ	1
Aberg, JA; Cardoso, SW; de Lacerda, MVG; Douglas, PS; Fitch, KV; Grinspoon, SK; Kantor, A; McComsey, G; Mohapi, L; Mosepele, M; Muntner, P; Overton, ET; Patil, S; Ribaudo, H; Supparatpinyo, K; Wyatt, CM	1
Beaubrun, A; Cummings, TH; Hardin, JW; Hsu, LI; Magagnoli, J; Majethia, S; Sutton, SS	1
Arai, T; Asai, A; Atsukawa, M; Cheung, R; Chien, N; Chuma, M; Dang, H; Fukunishi, S; Henry, L; Hoang, J; Huang, DQ; Ishikawa, T; Landis, C; Le, RH; Leong, J; Lim, SG; Liu, J; Maeda, M; Nguyen, MH; Quek, SXZ; Senoo, T; Takaguchi, K; Thin, KN; Toyoda, H; Tran, S; Trinh, HN; Uojima, H; Watanabe, T; Yasuda, S; Yokohama, K	1
Chen, R; Estrella, MM; Grunfeld, C; Horberg, MA; Hsue, PY; Jotwani, V; Scherzer, R; Shlipak, MG	1
Anugulruengkitt, S; Bunupuradah, T; Chanakul, A; Jantarabenjakul, W; Phupitakphol, T; Prasitsuebsai, W; Puthanakit, T; Ruxrungtham, K; Sopa, B; Sophonphan, J	1
Chen, M; Chow, EP; Fairley, CK; Medland, NA; Read, TR; Walker, RG	1
Atta, MG; Estrella, MM; Jotwani, V	1
Goorhuis, A; Kooij, KW; Post, FA; Prins, M; Reiss, P; van der Valk, M; van Zoest, RA; Vogt, L; Wit, FWNM	1
Gatanaga, H; Matsumoto, S; Mizushima, D; Nguyen, DT; Nguyen, DTH; Oka, S; Tanuma, J; Trung, NV; van Kinh, N	1
Chan, HL; Lam, KL; Lui, GC; Szeto, CC; Tse, YK; Wong, GL; Wong, VW; Yip, TC	1
Agyei, NA; Cotton, M; Frigati, L; Machemedze, T; Mahtab, S; Myer, L; Nourse, P; Perrazzo, S; Ray, P; Zar, H	1
Szeto, CC; Wong, GL; Wong, VW	1
Ni, W; Wang, J; Wu, Z; Xin, H	1
Liang, LY; Wong, GL	1
Gandhi, RT; Rosales, IA; Wojciechowski, D	1
Bastard, JP; Capeau, J; Costagliola, D; Eme, AL; Esteve, E; Fellahi, S; Guiard-Schmid, JB; Lebrette, MG; Lescure, FX; Pialoux, G; Plaisier, E; Ronco, P	1
Chan, TM; Fung, J; Lai, CL; Liu, SH; Mak, LY; Seto, WK; Wong, DK; Yap, DY; Yuen, MF	1
Asselineau, J; Bonnet, F; Chêne, G; Dauchy, FA; Déti, E; Duffau, P; Gerard, Y; Lazaro, E; Morlat, P; Neau, D; Vandenhende, MA; Vivot, A	1
Badiou, S; Chatron, M; Cournil, A; Cristol, JP; Guiller, E; Peyriere, H; Psomas, C; Reynes, J	1
Dung, NT; Gatanaga, H; Kanaya, F; Kikuchi, Y; Kinh, NV; Lam, NT; Mizushima, D; Nishijima, T; Oka, S; Tanuma, J	1
Cholongitas, E; Papatheodoridis, G; Pipili, C	1
Deeks, SG; Estrella, MM; Gandhi, M; Grunfeld, C; Peralta, CA; Scherzer, R; Shlipak, MG; Tien, PC	1
Barth, RE; Bauer, MP; Hoepelman, AI; Reiss, P; Schoffelen, AF; Smit, C; van Lelyveld, SF; Vogt, L	1
Estrella, MM; Ix, JH; Kim, JE; Scherzer, R; Shlipak, MG	1
Fux, CA; Kirk, O; Lundgren, JD; Mocroft, A; Monforte, Ad; Moranne, O; Morlat, P; Reiss, P; Ross, M; Ryom, L	1
Estrella, MM; Machekano, R; Moosa, MR; Nachega, JB; Taljaard, JJ; Uthman, OA; Veldkamp, PJ; Zachor, H; Zeier, MD	1
Achhra, AC; Mocroft, A; Nugent, M; Ryom, L; Wyatt, CM	1
Jones, R; Levy, JB; Milburn, J	1
Custodio, JM; Fordyce, M; Garner, W; Kearney, BP; Ling, KH; Ramanathan, S; Vimal, M	1
Chen, CH; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Tsai, MC; Wang, JH	1
Bedimo, RJ; Drechsler, H; Tebas, P; Vidiella, G; Westfall, AO	1
Bräu, N; Chang, MH; Fung, HB; Monteagudo-Chu, MO	1
Engsig, FN; Feldt-Rasmussen, B; Gerstoft, J; Kirk, O; Kronborg, G; Obel, N; Pedersen, C; Rasch, MG	1
Crane, HM; Eron, JJ; Kalayjian, RC; Kitahata, MM; Krishnasami, Z; Lau, B; Martin, JN; Mechekano, RN; Moore, RD; Rodriguez, B; Salata, RA; Willig, JH	1
Bartlett, H; Gibson, A; Kelly, MD; Patten, J; Rowling, D	1
Chernoff, MC; Hazra, R; Kopp, JB; Mofenson, LM; Patel, K; Purswani, M; Scott, GB; Seage, GR; Siberry, GK; Van Dyke, RB	1

Reviews

6 review(s) available for tenofovir and Chronic Kidney Diseases

Article	Year
Medication safety in chronic kidney disease. Current opinion in nephrology and hypertension, 2023, 09-01, Volume: 32, Issue:5 Topics: Adenine; COVID-19; Humans; Kidney; Renal Insufficiency; Renal Insufficiency, Chronic; Tenofovir	2023
Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy. Journal of the American Society of Nephrology : JASN, 2017, Volume: 28, Issue:11 Topics: AIDS-Associated Nephropathy; Anti-Retroviral Agents; Apolipoprotein L1; Apolipoproteins; HIV Infections; Humans; Kidney Transplantation; Lipoproteins, HDL; Renal Insufficiency, Chronic; Risk Factors; Tenofovir	2017
Unmet need in chronic hepatitis B management. Clinical and molecular hepatology, 2019, Volume: 25, Issue:2 Topics: Alanine Transaminase; Antiviral Agents; Drug Resistance, Viral; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Prognosis; Renal Insufficiency, Chronic; Tenofovir	2019
Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease. Alimentary pharmacology & therapeutics, 2014, Volume: 39, Issue:1 Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates; Renal Insufficiency, Chronic; Telbivudine; Tenofovir; Thymidine	2014
Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments. Current HIV/AIDS reports, 2016, Volume: 13, Issue:3 Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; Humans; Longitudinal Studies; Prevalence; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Tenofovir	2016
Renal effects of novel antiretroviral drugs. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2017, 03-01, Volume: 32, Issue:3 Topics: Adenine; Alanine; Anti-HIV Agents; Atazanavir Sulfate; Cobicistat; Creatinine; Disease Progression; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Oxazines; Piperazines; Proteinuria; Pyridones; Quinolones; Raltegravir Potassium; Renal Insufficiency, Chronic; Tenofovir	2017

Trials

2 trial(s) available for tenofovir and Chronic Kidney Diseases

Article	Year
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus. The Journal of infectious diseases, 2020, 07-09, Volume: 222, Issue:Suppl 1 Topics: Cohort Studies; Comorbidity; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Quinolines; Renal Insufficiency, Chronic; Statistical Distributions; Tenofovir	2020
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. The lancet. HIV, 2016, Volume: 3, Issue:1 Topics: Adolescent; Adult; Anti-HIV Agents; Atazanavir Sulfate; Australia; Europe; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Tenofovir; United States; Young Adult	2016

Article

Year

An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.

The Journal of infectious diseases, 2020, 07-09, Volume: 222, Issue:Suppl 1

Topics: Cohort Studies; Comorbidity; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Quinolines; Renal Insufficiency, Chronic; Statistical Distributions; Tenofovir

2020

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.

The lancet. HIV, 2016, Volume: 3, Issue:1

Topics: Adolescent; Adult; Anti-HIV Agents; Atazanavir Sulfate; Australia; Europe; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Tenofovir; United States; Young Adult

2016

Other Studies

36 other study(ies) available for tenofovir and Chronic Kidney Diseases

Article	Year
Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study. Hepatology international, 2022, Volume: 16, Issue:2 Topics: Adenine; Alanine; Antiviral Agents; Cohort Studies; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Renal Insufficiency, Chronic; Retrospective Studies; Tenofovir; Treatment Outcome	2022
Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort study. Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:4 Topics: Adenine; Adult; Alanine; Antiviral Agents; DNA, Viral; Hepatitis B, Chronic; Humans; Renal Insufficiency, Chronic; Retrospective Studies; Tenofovir; Treatment Outcome	2022
Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:11 Topics: Adenine; Alanine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Kidney; Longitudinal Studies; Maleates; Organophosphonates; Renal Insufficiency, Chronic; Retrospective Studies; Tenofovir; Treatment Outcome	2022
Performance of Creatinine- and Cystatin C-Based Equations for Glomerular Filtration Rate Estimation in HIV-1-Infected Individuals Receiving Dolutegravir + Tenofovir Disoproxil Fumarate + Lamivudine as Initial Antiretroviral Therapy: A Retrospective Observ Journal of acquired immune deficiency syndromes (1999), 2022, 10-01, Volume: 91, Issue:S1 Topics: Adult; Creatinine; Cystatin C; Female; Glomerular Filtration Rate; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Oxazines; Piperazines; Pyridones; Renal Insufficiency, Chronic; Retrospective Studies; Tenofovir	2022
Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration. The Journal of antimicrobial chemotherapy, 2023, 06-01, Volume: 78, Issue:6 Topics: Adenine; Alanine; Anti-HIV Agents; HIV Infections; Humans; Renal Insufficiency, Chronic; Tenofovir	2023
[Low Body Mass Index and impact of antiretroviral therapy on nephrotoxicity, chronic renal disease among HIV-infected patients in Brazzaville, Congo]. Nephrologie & therapeutique, 2020, Volume: 16, Issue:2 Topics: Adult; Antiviral Agents; Body Mass Index; Cohort Studies; Congo; Female; HIV Infections; Humans; Incidence; Kidney Diseases; Male; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Tenofovir	2020
Medium-grade proteinuria is a risk factor for incident markers of chronic kidney disease. HIV medicine, 2020, Volume: 21, Issue:8 Topics: Adult; Age Factors; Anti-HIV Agents; Biomarkers; Disease Progression; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Practice Guidelines as Topic; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Tenofovir	2020
Association of tenofovir disoproxil fumarate exposure with chronic kidney disease and osteoporotic fracture in US veterans with HIV. Current medical research and opinion, 2020, Volume: 36, Issue:10 Topics: Adult; Aged; Anti-HIV Agents; Cohort Studies; Female; HIV Infections; Humans; Logistic Models; Male; Middle Aged; Osteoporotic Fractures; Renal Insufficiency, Chronic; Tenofovir; Veterans	2020
Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice. Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:2 Topics: Adult; Aged; Alanine; Alanine Transaminase; DNA, Viral; Drug Substitution; Female; Glomerular Filtration Rate; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney; Liver; Liver Function Tests; Male; Middle Aged; Prodrugs; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Tenofovir	2021
Association of Tenofovir Use With Risk of Incident Heart Failure in HIV-Infected Patients. Journal of the American Heart Association, 2017, Apr-24, Volume: 6, Issue:4 Topics: Adult; Anti-HIV Agents; Cohort Studies; Databases, Factual; Female; Heart Failure; HIV Infections; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Tenofovir; United States; United States Department of Veterans Affairs	2017
Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents. The Pediatric infectious disease journal, 2018, Volume: 37, Issue:1 Topics: Adolescent; Anti-HIV Agents; Child; Creatinine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Male; Prevalence; Proteinuria; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Tenofovir; Thailand	2018
Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate. International journal of STD & AIDS, 2018, Volume: 29, Issue:3 Topics: Adult; Anti-HIV Agents; Australia; Creatinine; Fanconi Syndrome; HIV Infections; Humans; Incidence; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Tenofovir	2018
Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls. The Journal of infectious diseases, 2017, 09-15, Volume: 216, Issue:6 Topics: Albuminuria; Anti-HIV Agents; Case-Control Studies; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Phosphates; Prevalence; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Tenofovir	2017
Tenofovir disoproxil fumarate co-administered with lopinavir/ritonavir is strongly associated with tubular damage and chronic kidney disease. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:7 Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Kidney Tubules; Lopinavir; Male; Middle Aged; Renal Insufficiency, Chronic; Risk Factors; Ritonavir; Tenofovir; Vietnam	2018
Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment. Alimentary pharmacology & therapeutics, 2018, Volume: 48, Issue:9 Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Disease Progression; Female; Glomerular Filtration Rate; Guanine; Hepatitis B, Chronic; Humans; Middle Aged; Registries; Renal Insufficiency, Chronic; Tenofovir; Treatment Outcome	2018
Prevalence of risk factors for chronic kidney disease in South African youth with perinatally acquired HIV. Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:2 Topics: Adolescent; Africa South of the Sahara; Albuminuria; Anti-Retroviral Agents; CD4 Lymphocyte Count; Child; Comorbidity; Female; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Male; Prevalence; Renal Insufficiency, Chronic; Risk Factors; Tenofovir; Viral Load	2019
Letter: chronic kidney disease risk in patients with chronic hepatitis B-authors' reply. Alimentary pharmacology & therapeutics, 2018, Volume: 48, Issue:11-12 Topics: Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Renal Insufficiency, Chronic; Tenofovir	2018
Letter: chronic kidney disease risk in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics, 2018, Volume: 48, Issue:11-12 Topics: Guanine; Hepatitis B, Chronic; Humans; Renal Insufficiency, Chronic; Tenofovir	2018
Case 11-2019: A 49-Year-Old Man with HIV Infection and Chronic Kidney Disease. The New England journal of medicine, 2019, Apr-11, Volume: 380, Issue:15 Topics: AIDS-Associated Nephropathy; Anti-Retroviral Agents; Diagnosis, Differential; Drug Resistance, Viral; Glomerulosclerosis, Focal Segmental; Hepatitis C; HIV Infections; HIV-1; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Renal Insufficiency, Chronic; Tenofovir	2019
Prevalence of tubulopathy and association with renal function loss in HIV-infected patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2020, 04-01, Volume: 35, Issue:4 Topics: Adult; Anti-HIV Agents; Biomarkers; Ethnicity; Female; France; Glomerular Filtration Rate; HIV; HIV Infections; Humans; Kidney Tubules; Male; Middle Aged; Prevalence; Prospective Studies; Renal Insufficiency, Chronic; Tenofovir	2020
In Vitro and In Vivo Renoprotective Effects of Telbivudine in Chronic Hepatitis B Patients Receiving Nucleotide Analogue. Digestive diseases and sciences, 2019, Volume: 64, Issue:12 Topics: Activating Transcription Factor 4; Adenine; Antiviral Agents; Apoptosis; Caspase 12; Cell Line; Cell Survival; Endoplasmic Reticulum Chaperone BiP; Epithelial Cells; Female; Glomerular Filtration Rate; Heat-Shock Proteins; Hepatitis A Virus Cellular Receptor 1; Hepatitis B, Chronic; Humans; In Vitro Techniques; Interleukin-18; Kidney Tubules; Lamivudine; Lipocalin-2; Male; Middle Aged; Organophosphonates; Prospective Studies; Protective Agents; Renal Insufficiency, Chronic; Severity of Illness Index; Telbivudine; Tenofovir	2019
Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012. PloS one, 2013, Volume: 8, Issue:6 Topics: Adenine; Age Factors; Anti-Retroviral Agents; Cohort Studies; Contraindications; Female; France; Glomerular Filtration Rate; HIV Infections; Humans; Incidence; Kaplan-Meier Estimate; Male; Organophosphonates; Poisson Distribution; Prospective Studies; Protease Inhibitors; Regression Analysis; Renal Insufficiency, Chronic; Risk Factors; Sex Factors; Tenofovir	2013
Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥ 60 ml/min per 1.73 m2. AIDS (London, England), 2013, May-15, Volume: 27, Issue:8 Topics: Adenine; Adult; Aged; Anti-HIV Agents; Cross-Sectional Studies; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Organophosphonates; Proteinuria; Regression Analysis; Renal Insufficiency, Chronic; Risk Factors; Tenofovir	2013
WHO antiretroviral therapy guidelines 2010 and impact of tenofovir on chronic kidney disease in Vietnamese HIV-infected patients. PloS one, 2013, Volume: 8, Issue:11 Topics: Adenine; Adult; Anti-HIV Agents; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Organophosphonates; Renal Insufficiency, Chronic; Tenofovir; Vietnam	2013
A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans. AIDS (London, England), 2014, Jun-01, Volume: 28, Issue:9 Topics: Adenine; Adult; Anti-HIV Agents; Cohort Studies; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Prospective Studies; Renal Insufficiency, Chronic; Risk Assessment; Tenofovir; Veterans	2014
Diminished impact of ethnicity as a risk factor for chronic kidney disease in the current HIV treatment era. The Journal of infectious diseases, 2015, Jul-15, Volume: 212, Issue:2 Topics: Adenine; Adult; Africa South of the Sahara; Anti-HIV Agents; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Middle Aged; Netherlands; Organophosphonates; Prevalence; Renal Insufficiency, Chronic; Risk Factors; Tenofovir	2015
Tenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected veterans. AIDS (London, England), 2016, Apr-24, Volume: 30, Issue:7 Topics: Adult; Anti-HIV Agents; Bicarbonates; HIV Infections; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Risk Assessment; Serum; Tenofovir; United States; Veterans	2016
Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens. AIDS (London, England), 2016, 05-15, Volume: 30, Issue:8 Topics: Adult; Anti-HIV Agents; Disease Progression; Female; Glomerular Filtration Rate; HIV Infections; Humans; Incidence; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; South Africa; Tenofovir	2016
Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9 Topics: Adenine; Aged; Alanine; Anti-HIV Agents; Area Under Curve; Case-Control Studies; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Tenofovir	2016
Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs. Journal of the Formosan Medical Association = Taiwan yi zhi, 2017, Volume: 116, Issue:7 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Renal Insufficiency, Chronic; Telbivudine; Tenofovir; Thymidine; Treatment Outcome	2017
Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Jul-01, Volume: 53, Issue:1 Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Female; HIV Infections; Humans; Ischemic Attack, Transient; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Organophosphonates; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Stroke; Tenofovir; United States; United States Department of Veterans Affairs	2011
Renal toxicity of long-term therapy with tenofovir in HIV-infected patients. Journal of pharmacy practice, 2012, Volume: 25, Issue:5 Topics: Adenine; Adult; Anti-HIV Agents; Dideoxynucleosides; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Hospitals, Veterans; Humans; Incidence; Kidney; Male; Middle Aged; New York City; Organophosphonates; Outpatient Clinics, Hospital; Pilot Projects; Proportional Hazards Models; Renal Insufficiency, Chronic; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir	2012
Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study. Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:9 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cohort Studies; Denmark; Female; Glomerular Filtration Rate; HIV Infections; Humans; Incidence; Kidney; Linear Models; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Renal Insufficiency, Chronic; Tenofovir	2012
Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS (London, England), 2012, Sep-24, Volume: 26, Issue:15 Topics: Adenine; Adult; AIDS-Associated Nephropathy; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Creatinine; Female; Glomerular Filtration Rate; Hepatitis C; HIV Seropositivity; HIV-1; Humans; Incidence; Male; Middle Aged; Organophosphonates; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Ritonavir; Tenofovir; United States; Viral Load	2012
Tenofovir-associated proteinuria. AIDS (London, England), 2013, Jan-28, Volume: 27, Issue:3 Topics: Adenine; Anti-HIV Agents; Creatine; Female; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Proteinuria; Renal Insufficiency, Chronic; Tenofovir	2013
Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection. The Pediatric infectious disease journal, 2013, Volume: 32, Issue:5 Topics: Adenine; Adolescent; Anti-HIV Agents; Black or African American; Child; Cohort Studies; Female; Hispanic or Latino; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Male; Multivariate Analysis; Odds Ratio; Organophosphonates; Prevalence; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Statistics, Nonparametric; Tenofovir; United States	2013